https://www.thebodypro.com/collection/croi-2021-hiv
CROI 2021 virtual oral abstract session featuring speakers in tiny video boxes
Conference Coverage

CROI 2021 Data Bites: HIV Treatment and the Care Continuum

Our bite-sized study summaries include new research on antiretrovirals in development, trends in antiretroviral initiation speed and viral suppression rates in the U.S., and the link between gender-affirming surgery and an undetectable viral load.

By Myles Helfand and Larry Buhl

Featured

David Alain Wohl recaps CROI 2021 research during a video interview
Conference Coverage

CROI 2021 Highlights: New HIV Research With Clinical Impact

Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.

By Myles Helfand
clinical trial
Interviews

Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists

A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

By Terri Wilder, M.S.W.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

As CROI 2021 Attests, the PrEP Revolution Is Coming

Analysis from David Alain Wohl, M.D., on new research in on HIV prevention, especially in areas that will expand and transform PrEP options.

By David Alain Wohl, M.D.
injectable
News

Long-Acting ART Is Here. How Do We Make It Work for Our Patients?

Injectable HIV interventions are a game-changing new option for people dealing with pill fatigue, but there are implementation challenges for clinicians to consider.

By Larry Buhl
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

Broadly Neutralizing Antibodies for HIV? If We Can Do It for COVID ...

David Alain Wohl, M.D., shares his thoughts on broadly neutralizing antibodies for COVID-19—and the extent to which we can hope to see similar developments in HIV.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

Sleep and Diet: Don’t Underestimate Their Importance for People Living With HIV

David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

CROI 2021 Takeaway: Long-Acting Antiretrovirals for HIV Treatment

David Alain Wohl, M.D., talks through new data regarding long-acting antiretroviral therapy for HIV—and touches on the uncertainties clinicians face in incorporating this new treatment method into their practice.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps research from CROI 2021
Conference Coverage

Hypertension Control Emerges as Key Concern in Examination of HIV, Aging, and Cardiovascular Disease

David Alain Wohl, M.D., talks through new data presented at CROI 2021 that further our understanding of the interplay between HIV and comorbidities we often associate with aging, particularly those related to cardiovascular disease.

By David Alain Wohl, M.D.
photo of David Alain Wohl, M.D., as he recaps COVID-19 research from CROI 2021
Conference Coverage

HIV & COVID-19: CROI 2021 Reveals New Research

David Alain Wohl, M.D., analyzes updated data regarding the intersection of HIV and COVID-19, with a particular focus on SARS-CoV-2 susceptibility and disease severity.

By David Alain Wohl, M.D.
liver
Interviews

Hepatitis D Infection Poses Greater Risks to People Living With HIV, Study Finds

New research suggests a high prevalence of hepatitis D, the most severe form of viral hepatitis, in PLWH in regions of Europe, and a particularly high risk for people who inject drugs.

By Terri Wilder, M.S.W.